Letter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC?

Sanoff, Hanna K.Chang, YunKyungLund, Jennifer L.O'Neil, Bert H.Dusetzina, Stacie B.2017-08-022017-08-022017-08Sanoff, H. K., Chang, Y., Lund, J. L., O'Neil, B. H. and Dusetzina, S. B. (2017), Letter to the Editor: Immortal Time Bias or Sorafenib Effect in Elderly Patients with HCC?. Hepatology, 66 (2), 678-679. http://dx.doi.org/10.1002/hep.29250https://hdl.handle.net/1805/13696enPublisher Policysorafenibhepatocellular carcinomaimmortal time biasLetter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC?Article